TELESIS BIO

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch TELESIS BIO and buy or sell other stocks, ETFs, and their options commission-free!

About TBIO

Translate Bio, Inc. engages in the research and development of therapeutic drugs. It focuses on developing medicines to treat diseases caused by protein or gene dysfunction. 

CEO
Ronald C. Renaud, Jr., MBA
CEORonald C. Renaud, Jr., MBA
Employees
Employees
Headquarters
Lexington, Massachusetts
HeadquartersLexington, Massachusetts
Founded
2011
Founded2011
Employees
Employees

TBIO Key Statistics

Market cap
2.82B
Market cap2.82B
Price-Earnings ratio
74.36
Price-Earnings ratio74.36
Dividend yield
Dividend yield
Average volume
1.07M
Average volume1.07M
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$37.99
52 Week high$37.99
52 Week low
$11.91
52 Week low$11.91

Stock Snapshot

TELESIS BIO(TBIO) stock is priced at $0.00, giving the company a market capitalization of 2.82B. It carries a P/E multiple of 74.36.

During the trading day, TELESIS BIO(TBIO) stock saw an opening price of —, a peak of —, and a bottom of —.

Trading volume for TELESIS BIO(TBIO) stock has reached 0, versus its average volume of 1.07M.

Over the past 52 weeks, TELESIS BIO(TBIO) stock has traded between a high of $37.99 and a low of $11.91.

Over the past 52 weeks, TELESIS BIO(TBIO) stock has traded between a high of $37.99 and a low of $11.91.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.